| |
| |
|
| Insider
Information: |
Yver Antoine |
| Relationship: |
EVP & Chairman of Deve... |
| City: |
Cheshire |
| State: |
X0 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
783,066 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
783,066 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Centessa Pharmaceuticals Plc |
CNTA |
EVP & Chairman of Deve... |
2023-06-01 |
783,066 |
2021-05-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
22 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CNTA |
Centessa Pharmaceuticals ... |
EVP & Chairman of Development |
• – – |
2023-06-01 |
4 |
AS |
$4.45 |
$28,949 |
D/D |
(6,500) |
783,066 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
EVP & Chairman of Development |
• – – |
2023-05-01 |
4 |
AS |
$4.42 |
$30,083 |
D/D |
(6,800) |
789,566 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
EVP & Chairman of Development |
• – – |
2023-03-01 |
4 |
AS |
$3.42 |
$23,970 |
D/D |
(7,000) |
806,681 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
EVP & Chairman of Development |
• – – |
2023-02-01 |
4 |
AS |
$3.79 |
$29,201 |
D/D |
(7,700) |
813,681 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
EVP & Chairman of Development |
• – – |
2023-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
77,200 |
821,381 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
EVP & Chairman of Development |
• – – |
2023-01-04 |
4 |
AS |
$3.18 |
$22,136 |
D/D |
(6,970) |
751,913 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
EVP & Chairman of Development |
• – – |
2022-12-31 |
4 |
D |
$3.10 |
$7,031 |
D/D |
(2,268) |
758,883 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
EVP & Chairman of Development |
• – – |
2022-12-01 |
4 |
AS |
$3.91 |
$36,744 |
D/D |
(9,400) |
761,151 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
EVP & Chairman of Development |
• – – |
2022-11-01 |
4 |
AS |
$4.03 |
$39,055 |
D/D |
(9,700) |
765,059 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
EVP & Chairman of Development |
• – – |
2022-10-03 |
4 |
S |
$3.92 |
$49,053 |
D/D |
(12,524) |
774,759 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
EVP & Chairman of Development |
• – – |
2022-10-03 |
4/A |
AS |
$3.91 |
$37,108 |
D/D |
(9,500) |
780,251 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
EVP & Chairman of Development |
• – – |
2022-09-30 |
4 |
S |
$4.07 |
$10,038 |
D/D |
(2,468) |
787,283 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
EVP & Chairman of Development |
• – – |
2022-09-30 |
4 |
D |
$4.25 |
$32,861 |
D/D |
(7,732) |
782,019 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
EVP & Chairman of Development |
• – – |
2022-09-01 |
4 |
AS |
$4.41 |
$45,987 |
D/D |
(10,423) |
789,751 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
EVP & Chairman of Development |
• – – |
2022-08-01 |
4 |
AS |
$4.45 |
$46,405 |
D/D |
(10,423) |
800,174 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
EVP & Chairman of Development |
• – – |
2022-07-18 |
4 |
AS |
$4.87 |
$97,312 |
D/D |
(20,000) |
810,597 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
EVP & Chairman of Development |
• – – |
2022-07-01 |
4 |
S |
$5.03 |
$45,797 |
D/D |
(9,100) |
730,597 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
EVP & Chairman of Development |
• – – |
2022-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
830,597 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
EVP & Chairman of Development |
• – – |
2022-06-17 |
4 |
S |
$4.68 |
$43,036 |
D/D |
(9,200) |
739,697 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
EVP & Chairman of Development |
• – – |
2022-05-18 |
4 |
S |
$5.10 |
$330,102 |
D/D |
(64,778) |
748,897 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
EVP & Chairman of Development |
• – – |
2022-05-17 |
4 |
S |
$5.42 |
$109,632 |
D/D |
(20,222) |
813,675 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2021-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
833,897 |
833,897 |
0 |
- |
|
22 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
